Suvretta Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $52.8M | Hold |
|
|||||
|
2024
Q2 | $49.2M | Sell |
|
|||||
|
2024
Q1 | $68.3M | Sell |
|
|||||
|
2023
Q4 | $109M | Sell |
|
|||||
|
2023
Q3 | $111M | Buy |
|
|||||
|
2023
Q2 | $93.7M | Hold |
|
|||||
|
2023
Q1 | $110M | Buy |
|
|||||
|
2022
Q4 | $78M | Buy |
|
|||||
|
2022
Q3 | $74M | Sell |
|
|||||
|
2022
Q2 | $129M | Buy |
|
|||||
|
2022
Q1 | $78.9M | Buy |
|
|||||
|
2021
Q4 | $78.4M | Buy |
|
|||||
|
2021
Q3 | $55.2M | Buy |
|
|||||
|
2021
Q2 | $29.9M | Sell |
|
|||||
|
2021
Q1 | $41.7M | Sell |
|
|||||
|
2020
Q4 | $178M | Buy |
|
|||||
|
2020
Q3 | $118M | Buy |
|
|||||
|
2020
Q2 | $105M | Buy |
|